Pentostatin, cyclophosphamide and rituximab for previously untreated advanced stage, low-grade B-cell lymphomas

We conducted a prospective phase II trial of pentostatin, cyclophosphamide and rituximab as initial therapy for patients with previously untreated advanced stage low-grade or indolent B-cell lymphomas (iNHLs). Of 83 evaluable patients, 91·6% attained an overall response and 86·8% a complete or uncon...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Br J Haematol
Главные авторы: Samaniego, Felipe, Hagemeister, Fredrick, Romaguera, Jorge E., Fanale, Michelle A., Pro, Barbara, McLaughlin, Peter, Rodriguez, M. Alma, Neelapu, Sattva S., Fayad, Luis, Younes, Anas, Feng, Lei, Berkova, Zuzana, Khashab, Tamer, Sehgal, Lalit, Vega-Vasquez, Francisco, Kwak, Larry W.
Формат: Artigo
Язык:Inglês
Опубликовано: 2015
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5278955/
https://ncbi.nlm.nih.gov/pubmed/25828695
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.13367
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы